Not a good buy right now for an impatient trader: near-term pattern stats point to slight downside over the next day/week while technicals are neutral/indecisive.
Upside exists (analyst targets $4 and $7.75 vs. ~$3.76 pre-market), but the setup lacks a strong timing signal today.
Verdict: Hold and wait for a clearer momentum break (e.g., strength through resistance) rather than chasing the pre-market pop.
Technical Analysis
Pre-market: $3.76 (+3.01%), trading just above the pivot support area (Pivot: 3.568), which is constructive but not a confirmed breakout.
MACD histogram positive (0.109) but positively contracting → bullish momentum is fading, not accelerating.
RSI(6) ~50.84 (neutral) → no strong overbought/oversold edge.
Moving averages converging → consolidation/indecision; typically needs a catalyst or volume to resolve directionally.
Key levels:
Support: 3.568 (pivot), then 2.976 (S1)
Resistance: 4.16 (R1), then 4.526 (R2)
Pattern-based forward look provided: ~70% chance of -0.97% next day, -0.94% next week, +6.28% next month → short-term risk of chop/pullback despite better 1-month odds.
Positive Catalysts
would technically improve the trend picture.
Neutral/Negative Catalysts
No news in the past week → limited near-term event-driven fuel to push a breakout.
Short-term statistical outlook (next day/week) is slightly negative, which is not ideal for an impatient entry.
Profitability/quality concerns in the latest quarter snapshot: net income and EPS declined sharply YoY, implying earnings are not yet stable.
No notable recent hedge fund/insider accumulation signals (both reported as neutral).
Financial Performance
Latest quarter shown: 2025/Q3.
Revenue: $302,506, up +18,515.75% YoY (very large jump; likely influenced by base effects and/or business mix changes).
Net income: $5,830,582, down -173.92% YoY (directionally negative vs. prior year; suggests deterioration in profitability).
EPS: 0.2, down -102.21% YoY.
Gross margin: 100, down -101.24% YoY (as provided; indicates margin metrics are unstable/inconsistent).
Overall: top-line improved sharply, but earnings/margins trends are unfavorable/erratic, which weakens the “buy-now” case without a strong technical trigger.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend: new coverage initiations in Dec 2025, all bullish.
Cantor Fitzgerald (12/16): Overweight, $4 PT; thesis centered on Hyperliquid/HYPE and perps DEX share gains vs CEX.
Chardan (12/24): Buy, $7.75 PT.
Wall Street pros: constructive narrative exposure to a fast-growing crypto trading niche; targets imply upside vs. current price.
Wall Street cons: targets vary widely (signals uncertainty), and the financial snapshot shows weakening YoY profitability—so execution/earnings quality remains a key concern.
Wall Street analysts forecast HYPD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HYPD is 5.88 USD with a low forecast of 4 USD and a high forecast of 7.75 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast HYPD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HYPD is 5.88 USD with a low forecast of 4 USD and a high forecast of 7.75 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 3.460
Low
4
Averages
5.88
High
7.75
Current: 3.460
Low
4
Averages
5.88
High
7.75
Chardan
NULL -> Buy
initiated
$7.75
AI Analysis
2025-12-24
Reason
Chardan
Price Target
$7.75
AI Analysis
2025-12-24
initiated
NULL -> Buy
Reason
Chardan initiated coverage of Hyperion DeFi with a Buy rating and $7.75 price target.
Cantor Fitzgerald
Overweight
initiated
$4
2025-12-16
Reason
Cantor Fitzgerald
Price Target
$4
2025-12-16
initiated
Overweight
Reason
As previously reported, Cantor Fitzgerald initiated coverage of Hyperion DeFi with an Overweight rating and $4 price target. Hyperion is a Hyperliquid digital asset treasury company and Hyperliquid is a decentralized exchange for trading perpetual futures, built on its own custom layer-1 blockchain, notes the analyst, who sees HYPE, along with other perpetual DEX peers, taking share from centralized exchanges. HYPE DATs are an attractive way to gain exposure to HYPE, which the firm believes to be "one of the most attractive protocols across crypto," the analyst added.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for HYPD
